Acute myeloid leukemia with fms-like tyrosine kinase 3 (flt3) mutation / internal tandem duplication (itd) Clinical Trials

Delta Trials indexes 1 clinical trial for Acute myeloid leukemia with fms-like tyrosine kinase 3 (flt3) mutation / internal tandem duplication (itd) in its publicly accessible dataset. Of these, 0 enrolling participants at this time and 0 trials have reached completion. This research takes place spanning 7 research sites around the world. An additional 1 trial are in preparatory or other active non-recruiting stages. Since 2020, 1 trial were terminated, illustrating the dynamic nature of clinical research. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.